Metraipolis › archive › dc_67be3a96cc92
A comparison of the labeling of antineoplastic and supportive medicines in China, Japan, and the US based on the WHO essential medicines list — Europe PMC PMID:41357505
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41357505
- DOI
- 10.3389/fmed.2025.1600207
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T09:49:03.100Z
- SHA-256 of the archived text
342ac7c138925ea11823209ea4fe9129a11392112c4db3b13b9416bb1343c60f- Stable URL of this page
https://metraipolis.com/documento/dc_67be3a96cc92
How to cite
A comparison of the labeling of antineoplastic and supportive medicines in China, Japan, and the US based on the WHO essential medicines list — Europe PMC PMID:41357505 — Europe PMC (en), https://europepmc.org/article/MED/41357505 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_67be3a96cc92 (Metraipolis archive dc_67be3a96cc92, sha256 342ac7c138925ea11823209ea4fe9129a11392112c4db3b13b9416bb1343c60f)
BibTeX
@misc{dc67be3a96cc92,
title = {A comparison of the labeling of antineoplastic and supportive medicines in China, Japan, and the US based on the WHO essential medicines list — Europe PMC PMID:41357505},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41357505},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_67be3a96cc92; sha256 342ac7c138925ea11823209ea4fe9129a11392112c4db3b13b9416bb1343c60f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41357505. Agents can read the archived copy with the MCP tool read_document.